Physician profile
Isabel M Rojas
NPI 1972828804
$635.24
in general payments reported to CMS, 2019-2025
11 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.38 · 2022: $19.28 · 2023: $116 · 2024: $141 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $240.80 | 2022-2024 | Puraply |
| Abbott Laboratories | $116.42 | 2025 | Eterna |
| Kerecis Limited | $62.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mimedx Group, INC. | $35.84 | 2025 | |
| Pfizer INC. | $35.00 | 2024 | |
| Stryker Corporation | $33.13 | 2025 | Inbone |
| Integra Lifesciences Corporation | $27.38 | 2020 | |
| Orthofix Medical, INC. | $25.97 | 2025 | Physio-Stim |
| Vertex Pharmaceuticals Incorporated | $21.97 | 2025 | |
| Trice Medical, INC. | $18.80 | 2025 | |
| Biowound Solutions, INC. | $17.25 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.